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 1 
INTRODUCTION 
Cerebral palsy (CP) is a disorder of aberrant control of movement 
and posture, appearing early in life secondary to a central nervous system 
(CNS) lesion or dysfunction that is not the result of recognized 
progressive or degenerative brain disease. Children with CP face myriad 
challenges to normal growth.   
Vitamin D deficiency, known to occur in children with cerebral 
palsy is one such challenge and if left untreated can cause osteopenia and 
fractures. The reasons attributed are multifactorial and include poor 
sunlight exposure due to their nonambulant nature, nutritional impairment 
due to feeding difficulties and use of long term anticonvulsants in these 
children. 
Vitamin D deficiency is common even amongst normal children in 
India despite plenty of sunshine. All Indian studies point to low 25 
hydroxy vitamin D levels in the healthy normal pediatric population. The 
prevalence data of Vitamin D deficiency in healthy children from various 
studies in India and abroad ranged from 8% to 80% and the reason 
attributed is low intake of dietary calcium and phosphorus.  
 2 
Though the occurrence of Vitamin D deficiency in cerebral palsy is 
well described, the epidemiological data are sparse and hence it was 
decided to study the prevalence of vitamin D deficiency in children with 
cerebral palsy and to possibly identify the potential variables associated 
with increased risk. 
Definition of CP 
Cerebral Palsy describes a “group of disorders of the development 
of movement and posture, causing activity limitation that is attributed to 
non-progressive disturbances that occurred in the developing fetal or 
infant brain”. The motor disorders of cerebral palsy are often 
accompanied by disturbances of sensation, cognition, and 
communication, perception, with or without behaviour, and/or by a 
seizure disorder (1). 
Definition of vitamin D deficiency and insufficiency:  
Vitamin D insufficiency is defined as serum 25-hydroxyvitamin D 
levels below 30 ng/mL. 
Vitamin D deficiency is defined as serum 25-hydroxyvitamin D 
levels below 10 ng/mL (2). 
 3 
CEREBRAL PALSY 
The Cerebral palsy is the most common cause of childhood 
disability. The incidence of CP in developed world is 2-2.5/1000 live 
births (3). Evaluation of a child with CP requires a multidisciplinary 
approach with involvement of a dedicated “pediatrician or pediatric 
neurologist, a physiotherapist, occupational therapist, child psychologist, 
and a social worker”.  
Accurate and early diagnosis of CP is important for addressing co 
morbidities and also for social reasons. The “at risk” infants should be 
periodically evaluated after early diagnosis.  Probability of CP increases 
with prematurity, multiple pregnancies, and abnormal perinatal events. 
Abnormal neurological examination in infants helps in spotting ‘at risk’ 
children.  
In preterm infants, the presence of atypical features like dominant 
asymmetric tonic neck reflex (ATNR), paucity of movements of any of 
the limbs, hypotonia/hypertonia predict major motor dysfunction (4). 
Ultrasound abnormalities of “grade 2-4 leukomalacia” together with early 
visual and neurocognitive assessment data is a very good predictor for 
later neurodevelopment (5). All such patients who have risk factors or 
have abnormal neurological signs should be followed by careful 
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developmental assessment. A combination of low birth weight with 
hypertonus at 4 months of age is highly predictive of CP at 7 years as 
reported by Ellenberg et al (6). The early signs of CP are shown  in  
Table-1. 
TABLE - 1 
EARLY SIGNS OF CP 
a.  Excessive or disorganized movement or paucity of 
movement 
b. Abnormal stereotyped behavior 
c. Persistent  abnormalities of tone, high pitched shrill crying 
d. Feeding problems 
e. Arching of  neck and back 
f. Cortical thumb 
g. Delayed social smile 
h. Persistent ATNR 
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It is usually difficult to diagnose CP during the first half of infancy. 
This is due to the fact that some normal babies may show abnormal signs 
that clear up spontaneously. 
Cerebral palsy can be classified according to the timing of brain 
injury such as prenatal, perinatal or postnatal or based on pathology of 
brain injury e.g. vascular, infective, inflammatory or traumatic. The main 
divisions in the Edinburgh classification (7) are given in Table 2. 
TABLE – 2 
CLASSIFICATION OF CP 
 (a) Hemiplegia 
(b) Quadriplegia  
(c) Diplegia 
 (d) Ataxic CP 
 (e) Dyskinesia (including dystonia and athetosis) 
 (f) Any other form, including mixed forms 
 
 
 6 
Antenatal origin of Cerebral palsy is indicated by  preterm birth, 
microcephaly , presence of malformation, history of CP in a sibling, 
intrauterine growth retardation, and presence of  pore cephalic cyst or 
ventriculomegaly (8).  
Assessment of General Health:  
A CP child should be assessed for general health by assessing the 
child’s nutritional status with anthropometry and signs of vitamin 
deficiency. Disturbances in growth like limb length discrepancies might 
be there in hemiplegia or diplegia due to CP itself. Difficulties 
encountered in feeding are the most important cause of inadequate 
growth. Lack of sunlight exposure and antiepileptic usage contributes to 
rickety features. Lower respiratory infections are common due to repeated 
aspirations. Head circumference should be plotted serially to assess brain 
growth and microcephaly.  Neurocutaneous markers should be searched 
for. A complete physical and systemic examination should be done to rule 
out other malformations. 
A CP child’s nutritional requirements are not the same as for a 
normal child. The requirement should be based on the anthropometric 
measures.  Length is difficult to measure due to extensive deformities, 
contractures and dislocations. Alternatively, segmental limb and trunk 
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measures can be used to compute approximate length. Skin fold thickness 
using harpenden’s calipers can be used as a better measure of nutritional 
status (9). 
Assessment of Feeding and Nutrition:  
A CP child is unable to express hunger, unable to ask for food and 
unable to feed themselves. This associated with their oromotor 
dysfunction leads to problems in feeding due to thrusting of tongue, tonic 
bite, and difficulty in chewing, difficulty in co coordinating swallowing 
(10). Choking due to repeated aspirations due to ineffective cough 
mechanism and increased Gastro esophageal Reflux due to lax Lower 
Esophageal Sphincter may cause problems with feeding. 
Proper history should be taken regarding the child’s usual diet, 
preferences and what the child chokes on while feeding. A trained 
therapist should observe the feeding of the baby and try to improve 
feeding. A contrast study with barium or fluoroscopic analysis can help in 
assessing the nature of feeding problems and also in recognizing 
aspiration. Children with CP have numerous feeding difficulties affecting 
their nutritional uptake and these are further aggravated by lack of 
awareness among parents (11). 
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Orthopedic Problems: 
A thorough musculoskeletal system examination should be 
performed in children. Scoliosis, subluxation or dislocation of hip, 
contractures of tendoachilles and hamstrings, equinus deformity are the 
usually seen deformities. Reduced bone density as evidenced by bone 
densitometry and propensity to fractures with trivial injury sue to 
osteoporosis and extensive bone demineralization is common in children 
with cerebral palsy (12). Hip subluxation and dislocation may occur due 
to imbalance of adductors of the hip and flexors whose power is greater 
than the abductors of the hip and extensors (13). The dislocation causes 
considerable amount of pain if not treated.  The hip which is dislocated 
causes difficulty in the child’s ability to sit and hygiene of the perineum 
and causes scoliosis. At birth the hip joint is usually normal.  Subluxation 
of hip joint may progress by five and half percent every year, if left 
untreated.  Hip dysplasia can be assessed by examining for asymmetric   
folds of skin in the thigh and gluteal region. This is also done by Barlow 
and Ortolani tests in children. Those who are non ambulant, especially 
those children with spastic- quadriplegia are more prone to dislocate (14). 
Routine hip ultrasounds are recommended to pick up subluxation. 
Windswept deformity – “abduction attitude in one joint and adduction 
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attitude in the other joint due to contracture is seen with severe spastic 
CP”. 
Equinus deformity is the usual skeleto- muscular abnormality 
observed in children with Cerebral Palsy due to contracture of 
tendoachilles. This causes the typical tip toe gait or toe heel walking in 
children with Cerebral Palsy. 
SEIZURE DISORDER: 
Seizure disorder is very common in children with CP.  38% of 
children with Cerebral Palsy had epilepsy in a population based study 
(15). Numerous types of paroxysmal activity are seen in children with CP 
and differentiation from actual seizure would be difficult. All types of 
seizures may be seen in children with CP, though children with 
hemiplegic CP generally have localization related epilepsy. Seizure 
disorder in children with Cerebral Palsy is often refractory to treatment 
(16) and often requires multiple AEDs for seizure control. The etiology 
also may have bearing on the outcome.  CP caused by CNS infections or 
malformations or grey matter damage have higher prevalence of epilepsy 
than children with CP of other etiology, and their possibility of becoming 
free from seizures is rare. 
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VITAMIN D 
 Vitamin D is wrongly termed a vitamin as it can readily be 
synthesized in the skin.  Ultraviolet B radiation (wavelength 290 to 
315nm) penetrates the skin and 7-dehydrocholesterol is converted to 
previtamin D3, which is rapidly converted to vitamin D3 and 
hydroxylated to active form.  Excess previtamin D3 or vitamin D3 is 
destroyed by sunlight. Therefore excessive exposure to sunlight will not 
cause vitamin D3 intoxication.  
FIG – 1 : VITAMIN D SYNTHESIS 
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VITAMIN D DEFICIENCY: 
Vitamin D insufficiency is defined as serum 25-hydroxyvitamin D 
levels below 30 ng/mL. Overt vitamin D deficiency is defined as serum 
25-hydroxyvitamin D levels below 10 ng/mL (2). The stages and clinical 
signs of Vitamin D deficiency (17) are shown in table 3.  
Months before rickets becomes manifest, latent vitamin D 
deficiency is seen.  Recurrent respiratory tract infections, growth failure, 
lethargy, irritability are seen associated with vitamin D deficiency. (18–
21). 
25 OH vitamin D levels are to be measured and not 1,25OH 
vitamin D as  
- It may even be raised due to secondary hyperparathyroidism 
- It is an unstable fraction 
- Lasts for a shorter t- half 
- The amount normally seen in serum is several hundred times 
less than 25 OH vitamin D 
- And also because 25 OH vitamin D is the storage form of 
vitamin D. 
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VITAMIN D DEFICIENCY – STAGES AND CLINICAL SIGNS  
(table 3) 
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SUNLIGHT EXPOSURE AND VITAMIN D 
The main source of vitamin D is synthesis in the skin using 
cholesterol on exposure to UV-B light. When a light skinned individual is 
exposed to 10 to 15 minutes of whole body sunlight, within 24 hrs, 
10,000 to 20, 000 IU of vitamin D3 is generated;  darker  individuals need 
5 to 10 times more exposure to generate similar amounts of vitamin D3” 
(22-24). Production of Vitamin D on exposure to UV rays is dependent 
on lot of factors than just exposure time. These include pigmentation of 
skin, month of year, BMI, cloud cover, latitude, the amount of pollution 
of air, the body surface area exposed, and the extent from UV rays, 
including sunscreens and cloth cover (23,25,26).  
Skin pigmentation is most important in synthesis of vitamin D. But 
the necessary time of exposure for good synthesis in children cannot be 
determined. Indirect epidemiologic analysis now suggests that the age of 
onset at which direct sunlight exposure is initiated is even more important 
than the total sunlight exposure over a lifetime in determining the risk of 
skin cancer (27, 28).  
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VITAMIN D & CALCIUM SUPPLEMENTATION: 
Vitamin D supplements are necessary to all children from birth. 
Preterm  and low birth weight children should be supplemented vitamin 
D. Vitamin D supplementation should be given along with calcium 
supplementation to ensure good bone mineralization (29).Vitamin D 
deficiency, though biochemical and latent is observed in many normal 
healthy children and they are in danger of osteomalacia, overt rickets 
after some time or predisposed to recurrent respiratory tract infections. 
Diseases that predispose to fat malabsorption and thereby causing fat 
soluble vitamin deficiency remain deficient despite daily RDA intake of 
vitamin D and have to be supplemented with higher doses. Children on 
long term anticonvulsant medications are also found to be deficient in 
vitamin D in spite of daily RDA due to cytochrome P 450 induction and 
destruction of vitamin D. In such children, the dose of vitamin D is 
adjusted according to biochemical tests for 25 OH vitamin D levels and 
also bone densitometry assessment. 
   Best marker available to detect vitamin D levels is 25 OH vitamin 
D. It should be emphasized that serum level of 1, 25(OH) 2D is not a 
good indicator of vitamin D deficiency because of the reasons already 
explained. 
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ANTIEPILEPTIC DRUGS AND BONE STATUS 
  Bone health is very much affected by anti epileptic drug intake.  
Vitamin D helps in mineralization of the bone matrix in growing bones 
(30). Trabecular bone and growth plate is affected. Rickets has been 
reported in children treated with AEDs (31).  
Osteomalacia refers to softening of the bone due to decreased 
mineralization of the matrix of the bone. Rickets is not seen after 
completion of bone growth, while osteomalacia can be seen later also. 
The bone is involved while the growth plate is not. Drug-induced 
osteomalacia occurs secondary to AEDs and is well known.  
Osteoporosis refers to a decrease in the total bone mass 
predisposing them to frequent fractures. AED are well known to produce 
drug induced osteoporosis (33). Bone turnover markers may be increased 
in osteoporosis. Bone formation and resorption determines bone turnover, 
and both can be affected in osteoporosis. There is net increase in 
resorption over formation in osteoporosis.  
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TABLE - 4 
MARKERS OF BONE TURNOVER 
 Bone formation markers: 
 • Osteocalcin  
 • ALK (bone-specific) 
 •  Type I collagen  - Carboxy-terminal propeptide   
Bone resorption markers: 
 • N-telopeptide of collagen cross-links ,hydroxyproline 
 •  Type I collagen - Cross-linked C-telopeptide  
 
Markers of resorption are due to activity of osteoclasts, the cells 
that cause bone breakdown. Measurements of bone resorption are done in 
the serum or urine. Bone formation markers are procollagen markers, 
osteocalcin (or bone Gla protein) and bone-specific alkaline phosphatase. 
These markers assess the activity of osteoblasts, bone forming cells. By 
Valimaki et al, markers of  osteoclastic activity are elevated in patients 
with seizures receiving long-term treatment with Anti epileptic drugs (34) 
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and after recent initiation of therapy  with carbamazepine  by verrotti et al 
(35, 36).  Markers of bone formation have also been assessed in patients 
receiving AEDs. Increase in alkaline phosphatase have been seen in both 
children and adults receiving AED and the isoenzymes measured showed 
that the increase in total alkaline phosphatase was due to the bone 
fraction” (37, 38). According to Richen et al and another study by Sato 
biochemical abnormalities in adults receiving AEDs include 
“hypophosphatemia, hypocalcemia, decreased levels of  vitamin D 
metabolites, increased parathyroid hormone (PTH) levels, and increased 
levels of  bone resorption  markers and alkaline phosphatase” (34, 38-41). 
Pediatric studies reveal findings consistent with both increased and 
decreased bone turnover. Elevated markers of bone formation and 
resorption have been reported (35, 36). Compared with children who are 
not receiving AEDs, children who receive AEDs may have reduced Bone 
Mineral Density (42-45). The clinical significance of these findings is not 
clear, as there are no pediatric BMD reference databases. 
The abnormalities have been attributed to increased activity of the 
microsomal P-450 mixed-function oxidase system, resulting in increased 
conversion of vitamin D to inactive forms, inhibition of intestinal calcium 
transport directly, and independent of effects on vitamin D, and increased 
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bone resorption and turnover . Several theories (46) have been proposed 
to explain the link between AEDs and bone disease (Table 5). No single 
theory explains all the reported findings, and there may be multiple 
mechanisms. 
TABLE – 5 
PROPOSED MECHANISMS OF AED-RELATED BONE DISEASE 
 
• Induction of the    microsomal  cytochrome P450 enzyme 
 system and conversion of vitamin D to inactive metabolites. 
• Decreased calcium absorption 
• Altered response to parathormone 
• Impaired bone formation 
• Hyperparathyroidism 
• Altered bone resorption as evidenced by osteoclastic 
 activity 
• Deficiency of vitamin K 
• Deficiency of calcitonin 
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AEDs like phenobarbitone, phenytoin and carbamazepine are 
implicated in causing low vitamin D levels and rickets, osteomalacia and 
drug indced osteoporosis. (34-36,42,43).  Valproate, though not an 
enzyme inducer has also been studied and shown to cause decreased bone 
mineral density (40,44).  According to Akin R et al, in ambulant children 
with uncomplicated epilepsy, valproate therapy was associated with a 10 
to 14% reduction in BMD (40,43) but this effect was not consistently 
reproduced (47). Multiple new AEDs have been approved over the past 
10 years. Few studies have evaluated the effect of these newer 
medications on bone mineral metabolism and BMD (44,48,49). Though 
alteration in bone metabolism is not reported with newer antiepileptics as 
they are considered to be non enzyme inducers, it cannot be concluded 
that they do not have any alteration in bone homeostasis as evidenced in 
the case of valproate. Larger studies with newer antiepileptic drugs are 
necessary to prove this. 
FEEDING DIFFICULTIES IN CP 
Decreased food intake when compared to increased nutritional 
needs, oral - motor dysfunction and altered level of energy expenditure 
may very much contribute to the decreased nutritional status of the 
severely neurologically impaired cerebral palsy children. Inappropriate 
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dietary and energy uptake when compared to nutrient needs usually 
causes obesity, under nutrition in cerebral palsy children (51, 52). 
They are very much unable to express hunger, preferences of food, 
and satiety, leaving parents responsible for their food intake regulation. 
(53, 54).  The feeding process in these children is very difficult and needs 
dedication. The amount of food given may not be sufficient to meet the 
child’s energy needs. Problems in Oro - motor function are the most 
common reason in the pathogenesis of decreased nutrition and it 
corresponds with the severity of motor impairment (55, 56). Children 
may present with poor closure of lip, drooling of saliva and frequent 
thrusting of tongue, resulting in spillage of food particles (57).  
Swallowing may be slowed down, resulting in collection of food particles 
in the larynx or pyriform sinuses with propensity for frequent aspiration. 
Gastroesophageal reflux, which affects seventy five percent of 
cerebral palsy children, and prolonged gastric emptying, may account to 
the loss of vitamins and minerals because of frequent vomiting (58,59). 
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OSTEOPENIA AND CP 
Pathological fractures occur in severely spastic children due to 
inadequate mineralization of bone (60, 61). In a study by Hahn and 
another by Hendersen et al, factors responsible for reduced bone mineral 
density in these children are poor nutritional status, insufficient calcium 
intake, immobilization and use of anticonvulsants (41,62). 
CP children have decreased bone density compared to normal 
children and this predisposes them to pathological fractures even on 
trivial injury (63,64).This has been proven by BMD scans done on CP 
children which showed  extensive osteoporosis. 
Long bone fracture is a common problem in non-ambulant cerebral 
palsy (CP) children. This is because their non ambulant status results in 
increased bone resorption and increases the fragility of the bone. Up to 
20% sustain a femoral fracture during their lifetime (65). Other than 
fractures, deformities, subluxtions and dislocations are common due to 
altered power between opposing groups of muscles. 
Henderson et al found that more severe neurological dysfunction, 
usage of anticonvulsants and decreased triceps skin fold thickness 
predisposes to frequent fractures (64). 
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REVIEW OF LITERATURE 
Harinarayanan et al from Tirupathi, Andhra Pradesh studied the 
prevalence of vitamin D between normal urban and rural subjects. The 
study was conducted among urban adults and children and results were 
compared with   rural population with gender dispersion. The association 
with low calcium in the diet was studied and association was analyzed 
between vitamin D levels and the low dietary calcium. 81.5% urban 
males and 62.9% urban females were found to be deficient in vitamin D, 
14.8% of urban males and 25.7% of urban females were insufficient and 
3.7% of males and 11.4% of females in urban setting had normal vitamin 
D levels. In rural population, among males, deficiency, insufficiency and 
normal vitamin D values were seen in 76.5%, 14.7% and 8.8% 
respectively. Among rural females, 72.2% were deficient, 13.9% were 
insufficient, and 13.9% were found to be normal. The cut off value for 
vitamin D deficiency in the group was  taken as 20 ng/ml(66). 
In another study by Harinarayanan et al from Andhra Pradesh, 
low dietary intake of calcium, high phytate intake and high phytate to 
calcium ratio in diet predisposed to vitamin D deficiency (89).This study 
was done in tropical country India , in Andhra Pradesh, where  sunshine 
was 8 to 10 hours / day throughout the year. Only adults contributed to be 
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subjects of the study. Diet recall was done and dietary calcium, phytates 
and phytate to calcium ratio was studied in urban and rural individuals. 
The cut off value for vitamin D deficiency was taken as 20 ng/ml. It was 
found that urban men and women had mean vitamin D values of 18.54 
and 15.5 ng/ml respectively while the same in the rural population was 
23.7 and 19 ng/ml. This study proved that low dietary calcium intake was 
statistically significant to produce vitamin D deficiency and insufficiency 
(67). 
Marwaha et al conducted a study in Delhi among 5137 healthy 
children between ages of 10 and 18 of both sexes. Two socioeconomic 
strata were compared in this study. Clinical evidence of vitamin D 
deficiency was found in   10.2% of normal children. The mean vitamin D 
levels for the entire population were 11.8 ng/ml. The mean value for the 
low socioeconomic group was 10.4 ng/ml and the same for the upper 
socioeconomic group was 13.7 ng/ml. In the study, males were found to 
have higher mean concentrations higher than females. Also, vitamin D 
deficiency was found to be higher in the lower socioeconomic group than 
in the upper socioeconomic group, unlike other studies where the upper 
socioeconomic group showed a higher prevalence of vitamin D 
deficiency. The cut off values used in the study are severe 
 24 
hypovitaminosis < 5 ng/ml, moderate hypovitaminosis 5-10 ng/ml and 
mild hypovitaminosis 10-20 ng/ml (68). 
This study has also demonstrated that severe vitamin D deficiency 
(levels < 5ng/ml) was found in 8.6% in comparison to 23.5% in Finnish 
population studied by Ala – Houlala et al (69) and 45.2% in Chinese 
adolescents studied by Du X et al in Beijing  (70). 
Puri et al conducted a study in Delhi among 3127 school going 
girls in the age group of 6 -18 yrs. From the study group, 193 girls of 
lower socio economic status and 211 girls of upper socio economic status 
was converted into sub group and analyzed. In the subgroup, 29.9% of 
subjects were found to be vitamin D deficient of which 25.4% were from 
lower economic status and 34.1% was from higher socioeconomic status. 
The cut off value for vitamin D deficiency was taken as 10 ng/ml. Also, 
girls in higher socioeconomic status, though had good nutritional status 
and higher BMI, were found to be more deficient than their lower 
socioeconomic counterparts. Also studied was the mean sun exposure 
between both groups. Mean sunlight exposure which included playing; 
exercising outdoors, doing other household chores outside the house in 
sunlight was 45 min/ day in lower socioeconomic group while the same 
was 25 min/day for the higher socioeconomic group, which was found to 
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be statistically significant. Also, the mean body surface area exposed to 
sunlight among the 2 groups was 28 % and 15% in lower and higher 
economic groups respectively and the BSA exposure were found to be 
statistically significant (71). 
Varying cut off values used to define deficiency, insufficiency and 
normalcy in vitamin D values by different authors and different 
classifications makes it difficult in comparing the studies as it alters the 
number of children in the deficient group . A uniform criteria is necessary 
between studies to make comparison meaningful. Though the IOM and 
AAP have defined vitamin D deficiency and insufficiency to be 25 OH D 
values to be < 10 ng/ml and 10-30 ng/ml respectively and is being used 
worldwide, there is an increasing trend to use <20 ng/ml as cut off range 
to define vitamin D deficiency by different authors in face of emerging 
evidence that parathormone levels starts increasing with vitamin D values 
of < 20 ng/ml. There is no new consensus guidelines to define vitamin D 
deficiency to be <20 ng/ml and we have based our study according to the 
orginal guidelines drawn by IOM and AAP. 
In a study by Balalala et al, mother’s blood , cord blood and blood 
of the infants at 3 months of age were studied and all uniformly showed 
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low vitamin D levels in the insufficiency range proving that children of  
mother’s with low vitamin D are prone to be vitamin D deficient(72). 
Kumar et al conducted a large study in United States between the 
years 2001 to 2004 with sample size of 6275 among children 1 to 21 yrs, 
of which 9% of children were found to be vitamin D deficient. Another 
61% were found to be vitamin D insufficient. The cut off values for the 
study were taken to be <15 ng/ml for deficiency group and 15-30 ng/ml 
for the insufficiency group. The larger sample size and the time duration 
of the study ensures that all weather related factors influencing vitamin D 
deficiency  become well distributed throughout the group and the degree 
of error is very less (73). 
Renee et al studied the vitamin D status with risk factors in 
children with epilepsy. This study was conducted in an urban clinic 
consisting of patients on antiepileptics, mostly newer generation 
antiepileptics, although all groups of AED were represented. The cut off 
value to define vitamin D vitamin D insufficiency was more prevalent in 
the population than deficiency. Female gender, increased BMI, use of 
antiepileptics was considered significant risks for developing vitamin D 
deficiency. Mean level of Vitamin D was found to be 28.37 ng/ml with 
5% children alone in the deficiency range. (74). 
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Hendersen et al did a study on non institutionalized children with 
cerebral palsy in North Carolina. Calcidiol and calcitriol values were 
compared with different variables. Prevalence of vitamin D deficiency 
was 19%. Cut off value for deficiency was taken to be < 10 ng/ml. No 
statistical significance was found among the different variables analyzed 
relative to vitamin D levels (75). 
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AIM OF THE STUDY 
 The aim of the study is to find the prevalence of vitamin D 
status –Vitamin D deficiency and insufficiency in children with 
Cerebral Palsy and to compare them with normal children. 
 To identify the risk factors associated with Vitamin D 
deficiency in these children.  
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MATERIALS AND METHODS 
STUDY DESIGN 
 Case control study 
PLACE OF STUDY 
 Pediatric department, Kilpauk Medical College 
STUDY PERIOD 
 June 2012 to December 2012 
AGE GROUP 
 1 to 12 years 
INCLUSION CRITERIA:  
 Children with cerebral palsy attending the pediatric outpatient 
department and in patient care of our hospital contributed as the subjects 
of this study. Normal children were randomly selected as controls after 
informed consent. 
 
 30 
EXCLUSION CRITERIA: 
The following children with cerebral palsy were excluded from the 
study: 
 Children already on calcium supplementation 
 Children with evidence of renal or liver disease 
 Children with malabsorption syndromes 
 Children with family history of metabolic bone disease 
STUDY POPULATION 
 All children satisfying inclusion criteria 
CONTROLS 
 Age and sex matched controls 
MATERIALS AND METHODS 
 The study was approved by the ethical committee of our hospital. 
Informed consent was obtained for each subject, both cases and controls 
from their parent or guardian. There are no conclusive data regarding the 
prevalence of vitamin D deficiency in children with cerebral palsy. With 
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existing data, n was computed to be n=32. 32 cases were compared with 
32 age and sex matched controls. 
A detailed history was obtained including age, sex, birth history 
including mode of delivery, gestational age, birth weight, presence of 
birth asphyxia, neonatal seizures, developmental delay, exposure to 
sunlight, ambulatory status, seizures, use of antiepileptic drug (AED) 
(single/multiple drug, duration of treatment, type of antiepileptic drug), 
history of constipation and feeding difficulties . 
Complete physical examination of the child including 
anthropometry was performed with emphasis on evidence of fractures 
and dental changes. 
All children were subjected to the following investigations:  serum 
calcium-total, serum phosphorus, serum alkaline phosphatase (SAP) 
levels. These were determined by an automated analyzer. The 25 OH 
vitamin D levels were estimated by CLIA (chemi luminescence 
immunoassay) method. 
Vitamin D status in children with CP were analyzed with different 
variables including age, sex, type of CP and functional  grade of CP, 
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sunlight exposure, feeding difficulty, AED use, type of AED, laboratory 
data  and the statistical significance was determined. 
Weight less than 3
rd
 percentile for age and head circumference 
below 3
rd
 percentile according to IAP growth charts were considered to 
be wasting and microcephaly respectively. Total calcium above 9 mg/dl 
was considered to be normal. Serum phosphorus in the range of 4-7 mg/dl 
was considered to be in the normal range. SAP below 400 IU/l was 
considered normal.  
Functional staging of CP in cases was done. 
I No limitation of activity 
II Moderate limitation of activity 
III Moderate to great limitation of activity 
IV No useful physical activity. 
Vitamin D status in children with CP were analyzed with different 
variables including age, sex, type of CP, sunlight exposure, feeding 
difficulty, AED use, type of AED, laboratory data  and the statistical 
significance determined. The association between the type of AED and 
prevalence of Vitamin D deficiency was also analyzed. 
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STATISTICAL ANALYSIS OF DATA: 
The co relation between variables was analysed by chi square test. 
The means of the groups were compared by independent t test.  
The data analysis was computed using the SPSS v15 software and 
p value <0.05 was considered statistically significant.  
 Based on the data, the possible risk factors for vitamin D 
deficiency were postulated.  
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PROFORMA 
1. NAME: 
2. AGE / SEX: 
3. MRD No:  
4. ADDRESS: 
5. HISTORY: 
(i) Normal Delivery / Elective LSCS / Emergency LSCS 
(ii) Birth Asphyxia:   Yes / No 
(iii) Cried immediately after birth: Yes / No                    
(iv) Birth Wt:         <2.5 kg / >2.5 kg 
(v) Neonatal seizures: Yes / No   If Yes, cause: 
(vi) Breast fed: Yes / No 
(vii) Developmental delay: Yes / No                        
(viii) Epileptic: Yes / No   If Yes, How long? _____  
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(ix) On AEDs: Yes / No If Yes, How long? ______ 
(x) Feeding difficulties: Yes / No If Yes, choking / vomiting / ↑feeding 
time /others 
(xi) Time taken to feed: 
(xii) Exposure to sunlight: Yes / No                               
(xiii) Dental changes: Yes / No        
(xiv) Fractures / deformities: Yes / No    
6. ANTHROPOMETRY: 
Head circumference: ________cm     Weight: _________Kg 
Microcephaly: Yes / No       Wasting: Yes / No 
7. LAB VALUES: 
(i) Hemoglobin:      
(ii) Smear: Microcytosis / Macrocytosis / Dimorphic / others 
(iii) Total Calcium:     mg/dl 
 (iv) Serum Phosphorus:      mg/dl 
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(v) Serum Alkaline Phosphatase:          IU/l                                                       
8. MEDICATION DETAILS: 
(i) Antiepileptic drug: Phenytoin / Phenobarbitone / Valproate / 
Carbamazepine /  Topiramate / Lamotrigine / others    
(ii) No. of antiepileptic drug used:  
(iii) Duration of antiepileptic drug: <1yr / 1-3 yrs / >3yrs 
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RESULTS AND ANALYSIS 
A total of 32 children with cerebral palsy were subjects (cases) of 
the study. These children were analyzed with another 32 ages and sex 
matched normal children (controls). The demographic characteristics of 
the cases are as follows:  
 
10 (31.2%) children were below 3 years, 8 (25%) between 3-6 
years, 10 (31.2%) between 6-10years and 4 (12.5%) were in more than 10 
year age group. The mean age of cases was 5.9 years. 
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Majority of them (53.1%) were males and the rest 46.9% were 
females. 
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59.4% of them were spastic quadriparesis, spastic diplegia was 
12.5% and hemiplegia was 15.6%. 4 children belonged to dyskinetic 
group (12.5%) 
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Birth history details of all these children were analyzed with 
regards to the gestational age, mode of delivery, birth weight and history 
suggestive of birth asphyxia and the data are depicted on a graph as 
follows: 
 
While in controls, 12 (37.5%) were delivered normally, 10 (31.3%) 
each were emergency and elective LSCS. All 32 controls were term and 
had no birth asphyxia history. Only 2 controls (6.3%) were less than 2.5 
kg at birth while 30 (93.8%) were more than 2.5kg. Similarly 2 control 
children were not breast fed while a majority of 30 were exclusively fed.              
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All children in case group had developmental delay, 18.8% had 
neonatal seizures whereas seizures after neonatal period were found in 
75% of them. All 24 (75%) of them were on one or more antiepileptic 
drugs. 
 
 While in the control group none of them had developmental delay 
or neonatal seizures. Neither they were epileptic nor were they on anti 
epileptic medications. 
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As the study is on Vitamin D status in children with cerebral palsy 
where antiepileptic drugs are implicated to be one of the risk factor of 
vitamin D deficiency in these children, we gathered information on the 
number of AEDs used in each child, type of AED and the duration for 
which it is used to correlate with the vitamin D status in these children. 
 
It is clear from the graph that nearly half of the cases were on AED 
for more than 3 years. While 4 cases (12.5%) were taking drugs for less 
than one year, 5 cases (15.6%) were taking drugs for one to three years.  
Only 7 children (21.8%) were on monotherapy whereas majority 17 
(53.1%) of them were on more than one drug. 8 children (25%) were not 
on AED. Sodium valproate was the commonly used drug. 
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 The commonly observed co morbidities in cases with cerebral 
palsy were feeding difficulties (71.9%), constipation (28.2%), dental 
changes (56.2%) and fractures (12.5%) in that order. 
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The other parameter implicated in vitamin D deficiency in children 
with cerebral palsy is the poor sunlight exposure in these children, mainly 
due to their non ambulant nature. 10(31.25%) of them had poor sunlight 
exposure.  
 
Microcephaly was seen in 28 (87.5%) of the children. 30 children 
were non ambulant (functional grade 3 and above) while 2 were ambulant 
(grade 2 and below).  In our study, 6.3% belonged to grade II, 34.4% 
belonged to grade III and 59.4% came under grade IV. 
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Total calcium, serum phosphorus and serum alkaline phosphatase 
was done in all children (both cases and controls). In the case group , 24 
children (75%) had low total calcium and the rest 8 (25%) had normal 
total calcium. Low phosphorus was observed in 12 (37.5%) of the 
children. Serum Alkaline phosphatase (SAP) was normal in 17 (53.1%) 
whereas it was elevated in 15(46.9%).  
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The same was done for all the controls. Serum calcium was low in 
7 control children (21.9%) and normal in 25(78.1%). In these children 
alkaline phosphatase was normal in 26 (81.3%) and elevated in the rest 6 
(18.8%). Serum phosphorus was normal in all children. 
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Vitamin D deficiency was observed in 12 (37.5%) and 
insufficiency in 18 (56.3%) of children with cerebral palsy. 
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Similarly vitamin D status was studied in normal control children. 
It was found that majority of them 19 (59.4%) was normal. While 12 
(37.5%) were vitamin D insufficient, one child (3.1%) showed deficient 
levels 
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VITAMIN D CASES VS. CONTROLS 
Crosstab
12 1 13
37.5% 3.1% 20.3%
18 12 30
56.3% 37.5% 46.9%
2 19 21
6.3% 59.4% 32.8%
32 32 64
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
< 10
10 - 30
30 - 100
vit d
Total
Case Control
Group
Total
 
Chi-Square  Tests
24.270a 2 .000
28.083 2 .000
23.386 1 .000
64
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of  Valid Cases
Value df
Asymp. Sig.
(2-s ided)
0 cells (.0%) have expected count less than 5. The
minimum expected count is  6.50.
a. 
 
37.5% had vitamin D deficiency and 56.3% had insufficiency 
among CP children. Among, age and sex matched controls, 3.1% were 
found to be deficient and 37.5% were found to be insufficient. Decreased 
vitamin D levels were found to be statistically significant in the case 
group when compared to controls. 
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Multivariate analysis of Vitamin D status in children with CP 
and controls 
Variables Vitamin D status P value 
 
 
 
 
Sex 
Male 
Female 
 
Gestation 
Preterm 
Term 
 
Birth asphyxia 
Yes 
No 
 
Birth weight>2.5 
Yes 
No 
 
Neonatal seizures 
Yes 
No 
 
Breast feeding 
Yes 
No 
 
Epilepsy 
Yes 
No 
 
AED 
Yes 
No 
 
Feeding difficulty 
Yes 
No 
 
 
Sunlight 
Yes 
No 
 
 
 
CASES n=32 CONTROLS n=32  
 
 
P  > 0.05 
 
 
 
P  > 0.05 
 
 
 
P  > 0.05 
 
 
 
P  > 0.05 
 
 
 
P  > 0.05 
 
 
 
P  > 0.05 
 
 
 
P=0.000 
 
 
 
P=0.000 
 
 
 
P=0.01 
 
 
 
 
P=0.046 
 
 
 
DEFI- 
CIENCY 
INSUFF- 
ICIENCY 
NORMAL DEFI- 
CIENCY 
INSUFFI- 
CIENCY 
NORMAL 
 
7 
5 
 
 
1 
11 
 
 
5 
7 
 
 
11 
1 
 
 
3 
9 
 
 
10 
2 
 
 
12 
0 
 
 
12 
0 
 
 
11 
1 
 
 
 
7 
5 
 
 
 
9 
9 
 
 
4 
14 
 
 
4 
14 
 
 
14 
4 
 
 
1 
17 
 
 
18 
0 
 
 
11 
7 
 
 
11 
7 
 
 
11 
7 
 
 
 
13 
5 
 
 
 
1 
1 
 
 
0 
2 
 
 
2 
0 
 
 
2 
0 
 
 
2 
0 
 
 
2 
0 
 
 
1 
1 
 
 
1 
1 
 
 
1 
1 
 
 
 
2 
0 
 
 
 
0 
1 
 
 
0 
1 
 
 
0 
1 
 
 
1 
0 
 
 
0 
1 
 
 
1 
0 
 
 
0 
1 
 
 
0 
1 
 
 
0 
1 
 
 
 
1 
0 
 
 
 
8 
4 
 
 
0 
12 
 
 
0 
12 
 
 
12 
0 
 
 
0 
12 
 
 
12 
0 
 
 
0 
12 
 
 
0 
12 
 
 
0 
12 
 
 
 
12 
0 
 
 
 
9 
10 
 
 
0 
19 
 
 
0 
19 
 
 
19 
0 
 
 
0 
19 
 
 
19 
0 
 
 
0 
19 
 
 
0 
19 
 
 
0 
19 
 
 
 
19 
0 
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Dental 
Yes 
No 
 
 
 
Fracture 
Yes 
No 
 
 
Wasting 
Yes 
No 
 
8 
4 
 
 
 
 
2 
10 
 
 
 
12 
0 
 
7 
11 
 
 
 
 
1 
17 
 
 
 
13 
5 
 
2 
0 
 
 
 
 
0 
2 
 
 
 
1 
1 
 
0 
1 
 
 
 
 
0 
1 
 
 
 
0 
1 
 
0 
12 
 
 
 
 
0 
12 
 
 
 
0 
12 
 
0 
19 
 
 
 
 
0 
19 
 
 
 
0 
19 
 
P=0.02 
 
 
 
 
 
P > 0.5 
 
 
 
 
P=0.000 
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USAGE OF ANTIEPILEPTICS VS VITAMIN D 
Cross tab
12 0 12
100.0% .0% 92.3%
0 1 1
.0% 100.0% 7.7%
12 1 13
100.0% 100.0% 100.0%
11 0 11
61.1% .0% 36.7%
7 12 19
38.9% 100.0% 63.3%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 19 20
50.0% 100.0% 95.2%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
aed
Total
Yes
No
aed
Total
Yes
No
aed
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
           P=0.000 
Antiepileptic drug usage was found to be statistically highly 
significant when compared between cases and controls in both deficient 
and insufficient group. 
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DURATION OF AED VS. VITAMIN D 
Cross tab
1 0 1
8.3% .0% 7.7%
2 0 2
16.7% .0% 15.4%
9 0 9
75.0% .0% 69.2%
0 1 1
.0% 100.0% 7.7%
12 1 13
100.0% 100.0% 100.0%
3 0 3
16.7% .0% 10.0%
2 0 2
11.1% .0% 6.7%
6 0 6
33.3% .0% 20.0%
7 12 19
38.9% 100.0% 63.3%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 19 20
50.0% 100.0% 95.2%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
< 1
1 - 3
=> 3
Nil
duration
Total
< 1
1 - 3
=> 3
Nil
duration
Total
1 - 3
Nil
duration
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
                P= 0.005 
The number of years  of anti epileptic drugs  intake was found to be 
highly significant when compared between cases and controls in both the 
deficient and the insufficient group. 
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SEIZURE DISORDER VS. VITAMIN D  
          
Cross tab
12 0 12
100.0% .0% 92.3%
0 1 1
.0% 100.0% 7.7%
12 1 13
100.0% 100.0% 100.0%
11 0 11
61.1% .0% 36.7%
7 12 19
38.9% 100.0% 63.3%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 19 20
50.0% 100.0% 95.2%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
epilptic
Total
Yes
No
epilptic
Total
Yes
No
epilptic
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
         P =0.000 
Presence of seizure disorder was found to be statistically highly 
significant when compared between cases and controls in both deficient 
and insufficient group. This is due to the fact that all the patients with 
seizures were on regular anti epileptic therapy. 
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FEEDING DIFFICULTY VS. VITAMIN D 
Cross tab
11 0 11
91.7% .0% 84.6%
1 1 2
8.3% 100.0% 15.4%
12 1 13
100.0% 100.0% 100.0%
11 0 11
61.1% .0% 36.7%
7 12 19
38.9% 100.0% 63.3%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 19 20
50.0% 100.0% 95.2%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
fd
Total
Yes
No
fd
Total
Yes
No
fd
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
                                                                                                                          P=0.01 
Presence of feeding difficulty was found to be statistically 
significant in the case group when compared to controls in both deficient 
and insufficient group. 
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SUNLIGHT EXPOSURE VS VITAMIN D 
         
Crosstab
7 1 8
58.3% 100.0% 61.5%
5 0 5
41.7% .0% 38.5%
12 1 13
100.0% 100.0% 100.0%
13 12 25
72.2% 100.0% 83.3%
5 0 5
27.8% .0% 16.7%
18 12 30
100.0% 100.0% 100.0%
2 19 21
100.0% 100.0% 100.0%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
sunlight
Total
Yes
No
sunlight
Total
Yessunlight
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
              P=0.046 
Poor sunlight exposure was found to be statistically significant 
when compared between cases and controls in both deficient and 
insufficient group. 
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DENTAL CHANGES VS. VITAMIN D 
              
Cross tab
8 0 8
66.7% .0% 61.5%
4 1 5
33.3% 100.0% 38.5%
12 1 13
100.0% 100.0% 100.0%
7 0 7
38.9% .0% 23.3%
11 12 23
61.1% 100.0% 76.7%
18 12 30
100.0% 100.0% 100.0%
2 0 2
100.0% .0% 9.5%
0 19 19
.0% 100.0% 90.5%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
den
Total
Yes
No
den
Total
Yes
No
den
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
               P=0.02 
Dental changes of Vitamin D deficiency was found to be 
statistically significant in the case group when compared to controls in 
both deficient and insufficient group. 
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NUTRITIONAL STATUS VS. VITAMIN D 
             
Cross tab
12 0 12
100.0% .0% 92.3%
0 1 1
.0% 100.0% 7.7%
12 1 13
100.0% 100.0% 100.0%
13 0 13
72.2% .0% 43.3%
5 12 17
27.8% 100.0% 56.7%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 19 20
50.0% 100.0% 95.2%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Yes
No
w as
Total
Yes
No
w as
Total
Yes
No
w as
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
              P=0.000 
Poor nutritional status was found to be statistically significant 
when compared between cases and controls in both deficient and 
insufficient group to cause decreased vitamin D levels. 
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TYPE OF CEREBRAL PALSY VS. VITAMIN D 
Crosstab
2 0 2
16.7% .0% 15.4%
10 0 10
83.3% .0% 76.9%
0 1 1
.0% 100.0% 7.7%
12 1 13
100.0% 100.0% 100.0%
3 0 3
16.7% .0% 10.0%
8 0 8
44.4% .0% 26.7%
4 0 4
22.2% .0% 13.3%
3 0 3
16.7% .0% 10.0%
0 12 12
.0% 100.0% 40.0%
18 12 30
100.0% 100.0% 100.0%
1 0 1
50.0% .0% 4.8%
1 0 1
50.0% .0% 4.8%
0 19 19
.0% 100.0% 90.5%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Hemi
Quard
Nil
type
of  cp
Total
Hemi
Quard
Diple
Dysk
Nil
type
of  cp
Total
Quard
Dysk
Nil
type
of  cp
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
                P=0.002 
Similarly when type of cerebral palsy was analyzed between cases 
and controls it was seen to be highly significant in both the deficient and 
the insufficient group. 
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FUNCTIONAL GRADE VS. VITAMIN D 
Cross tab
0 1 1
.0% 100.0% 7.7%
2 0 2
16.7% .0% 15.4%
10 0 10
83.3% .0% 76.9%
12 1 13
100.0% 100.0% 100.0%
0 12 12
.0% 100.0% 40.0%
1 0 1
5.6% .0% 3.3%
9 0 9
50.0% .0% 30.0%
8 0 8
44.4% .0% 26.7%
18 12 30
100.0% 100.0% 100.0%
0 19 19
.0% 100.0% 90.5%
1 0 1
50.0% .0% 4.8%
1 0 1
50.0% .0% 4.8%
2 19 21
100.0% 100.0% 100.0%
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
Count
% w ithin Group
0
Grade III
Grade IV
f t grade
Total
0
Grade II
Grade III
Grade IV
f t grade
Total
0
Grade II
Grade IV
f t grade
Total
vit d
< 10
10 - 30
30 - 100
Case Control
Group
Total
 
                P=0.002 
When functional grades were compared between cases and controls 
it was found to be highly statistically significant in both deficiency and 
insufficiency groups to cause decreased vitamin D levels. 
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ANALYSIS OF LABORATORY DATA 
The mean values of various biochemical parameters are 
 
VITAMIN 
D 
CALCIUM PHOSPHORUS 
ALKALINE 
PHOSPHATASE 
 
CASE 
 
17.98 
 
8.21 
 
3.54 
 
431.3 
 
CONTROLS 
 
33.13 
 
9.32 
 
4.14 
 
289.44 
  
Laboratory data were analysed quantitatively. Calcium, 
phosphorus, alkaline phosphatase and vitamin D values were compared 
between cases and controls. 
The mean calcium and phosphorous levels among cases were 8.2 
and 3.5, while controls showed a mean value of 9.3 and 4.1 respectively. 
Mean alkaline phosphatase levels among cases were 431, and that of 
controls was 289. 
Mean Vitamin D levels among cases was 17.98  ng/ml while that 
of controls were 33.13ng/ml. 
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VITAMIN D DEFICIENCY  (<10 ng/ml )VS. LABORATORY 
DATA  
Group Statis tics
12 7.542 .6127 .1769
1 8.800 . .
12 3.167 .2570 .0742
1 3.800 . .
12 533.58 101.522 29.307
1 680.00 . .
Group
Case
Control
Case
Control
Case
Control
cal
phos
alp
N Mean Std. Deviation
Std. Error
Mean
 
Independent Samples  Test
. . -1.973 11 .074 -1.2583 .6377 -2.6619 .1452
. . . -1.2583 . . .
. . -2.367 11 .037 -.6333 .2675 -1.2221 -.0445
. . . -.6333 . . .
. . -1.386 11 .193 -146.417 105.668 -378.990 86.157
. . . -146.417 . . .
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
cal
phos
alp
F Sig.
Levene's Test for
Equality  of  Variances
t df Sig. (2-tailed)
Mean
Dif ference
Std. Error
Dif ference Low er Upper
95% Conf idence
Interval of  the
Dif ference
t-test for Equality  of  Means
 
Significant p value was found for phosphorous (p = 0.037) when 
the quantitative  lab data was analyzed by T test co relating vitamin D 
deficiency with laboratory data in cases and controls. 
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VITAMIN D INSUFFICIENCY (10 – 30 ng/ml) VS. LABORATORY 
DATA 
Group Statis tics
18 8.606 .6830 .1610
12 9.067 .4619 .1333
18 3.739 .5326 .1255
12 3.850 .2111 .0609
18 373.28 135.022 31.825
12 409.50 83.632 24.142
Group
Case
Control
Case
Control
Case
Control
cal
phos
alp
N Mean Std. Deviation
Std. Error
Mean
 
Independent Samples  Test
1.875 .182 -2.042 28 .051 -.4611 .2258 -.9236 .0014
-2.206 27.977 .036 -.4611 .2090 -.8893 -.0329
9.458 .005 -.684 28 .499 -.1111 .1623 -.4436 .2214
-.796 23.902 .434 -.1111 .1395 -.3992 .1770
.995 .327 -.827 28 .415 -36.222 43.806 -125.955 53.510
-.907 27.911 .372 -36.222 39.946 -118.060 45.615
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
cal
phos
alp
F Sig.
Levene's Test for
Equality  of  Variances
t df Sig. (2-tailed)
Mean
Dif ference
Std. Error
Dif ference Low er Upper
95% Conf idence
Interval of  the
Dif ference
t-test for Equality  of  Means
 
Significant p value was found for calcium (p = 0.036) when the 
quantitative data was analyzed by T test co relating vitamin D 
insufficiency ( 10 – 30 ng/ml) with quantitative laboratory data in cases 
and controls. 
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DISCUSSION 
Vitamin D deficiency is a common association in children with 
Cerebral Palsy due to known reasons like poor sunlight exposure, non-
ambulatory nature, anticonvulsant use and feeding difficulties. Though 
the association is existent and well described in literature, the 
epidemiological data available regarding the same is less. This made us to 
do this study to highlight the proportion of children with cerebral palsy 
who have Vitamin D deficiency and to compare them with normal 
controls to find statistical significance and also to identify the possible 
risk factors causing it to enable early identification, periodic monitoring 
and supplementation with calcium and vitamin D to prevent the 
development of fractures and deformities. 
In this study, we have tried to correlate the vitamin D status in 
children with cerebral palsy in relation to the nutritional status, 
anticonvulsant use, feeding difficulty, poor sunlight exposure, and type of 
CP and functional grade of CP which have been implicated as possible 
causes for vitamin D deficiency in these children. 
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VITAMIN D AND CP  
It is a popular belief that rickets and vitamin D deficiency are not 
common in India, a tropical country, because of abundant sunlight 
exposure. But there is now increasing evidence that this statement is not 
correct. Vitamin D deficiency has been well documented among all age 
groups like neonates, toddlers, school children, pregnant women, and 
adult males and females residing in rural and urban India. 
There are studies from both north and south India. (76, 66, 67) 
These studies clearly state the fact that approximately 75 to 85% of the 
groups studied have varying degrees of vitamin D deficiency or 
insufficiency (hypovitaminosis D). One more important data drawn out in 
these studies is the fact that dietary intake of vitamin D, nutrition and 
amount of sunlight exposure has a great impact on the vitamin D levels in 
the population. One of the studies has shown a big impact on dietary 
calcium supplementation to a group of children (67). 
The usage of different cut off points for vitamin D levels for 
insufficiency and deficiency by various authors has made it difficult to 
compare the results of published research by different authors and has 
complicated comparisons between different communities and 
populations. Also the latitude, solar zenith angle, uv radiation, amount of 
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cloud cover, time duration of exposure to sunlight, body surface area 
exposed to sunlight is different among different parts of the world and 
also different in various areas of our own country and therefore 
comparisons between the different groups are not possible. 
In our study, the prevalence of decreased vitamin D in cases was 
93.8 %. Whereas in our control population the prevalence of decreased 
vitamin D was 40.6%.  The prevalence of vitamin D deficiency in study 
group was 37.5% and insufficiency was 56.3%. In the control group, 
vitamin D deficiency amounted to 3.1%, while insufficiency amounted to 
37.5%. In both populations, insufficiency was found to be commoner 
than deficiency. There is a significant association between low vitamin D 
in CP children when compared to normal population.  
The prevalence of decreased vitamin D in our cases was 93.8 % 
which was statistically significant, while in the control group, decreased 
vitamin D levels amounted to 40.6%. This increased prevalence of  
decreased vitamin D levels in CP children is statistically significant and 
this is not an incidental occurrence but due to the multiple reasons  like 
feeding and swallowing issues resulting in poor nutrition, lack of 
adequate intake of calcium rich food, lack of exposure to sunlight and 
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added burden due to anti-epileptic medications whose analysis will 
follow. 
None of the controls showed any clinical signs of Vitamin D 
deficiency but alteration in serum calcium and alkaline phosphatase were 
noted in some children. 
The prevalence of vitamin D deficiency in CP children by 
Hendersen et al had a prevalence of deficiency of 19% while our study 
has a deficiency of 37.5%. Though the prevalence of vitamin D 
deficiency/insufficiency in normal population varied between 10% to   
70% in various studies, it was 40.6% in our normal controls (75).  
There have been no Indian studies to compare vitamin D levels and 
risk factor analysis in CP children and therefore mean vitamin D values 
cannot be compared with Indian population. Harinarayanan et al 
conducted a study about vitamin D status in general population in 
Tirupathi (66). As it is nearby our place of study and also enjoys the same 
amount of sunshine and cloud cover as our study place, the values of 
vitamin D and result analysis would be meaningful if compared with our 
population. The mean vitamin D levels of urban males in the above 
mentioned study was 18.54 ng/ml while in females it was 28.35 ng/ml. 
Among rural population, mean was 29.24 ng/ml for men and 29.21 ng/ml 
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for women. In our study, we have mean Vitamin D levels of 17.98 ng/ml. 
In our control population, we get a mean vitamin D value of  33.13 ng/ml.   
In a study by Marwaha et al in healthy school going children in 
North India, the mean vitamin D levels in low and high socioeconomic 
group were 10.4 and 13.7 ng/ml. While all studies uniformly report 
higher prevalence of vitamin D deficiency in higher socio economic, 
urban and white collared population, this study gives a 42.3% prevalence 
of 25 (OH)D deficiency in lower socioeconomic group when compared to 
higher socioeconomic group which had a 27% prevalence (68). In our 
study, the control population had a 3.1% and 37.5% prevalence of 
deficiency and insufficiency. This is one study which used the cut off 
value for deficiency as <10 ng/ml as in our study while other studies have 
used higher cut off of 20 ng/ml to define deficient state. In our study, the 
mean vitamin D levels among case group was 17.98 while that of the 
control group was 33.13 ng/ml. 
In a study by Balalala et al, who studied maternal, cord and infant 
blood sample vitamin D, the mean vitamin D levels was 22.99, 19.36, 
18.19 ng/ml respectively (72). The vitamin D levels of blood of infants 
was 18.19ng/ml. Our study population does not comprise infants.  
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In the United States, a study done by Kumar et al over four years in 
a large group of 6000 children reports that  9% of children were deficient 
and 61% were insufficient (73). Our study has a deficiency prevalence of 
3.1% and insufficiency prevalence of 37.5%. This study gives 
comparable results as the population as it was a large group and 
uniformly distributed to negate weather factors influencing vitamin D 
levels. 
Usage of either 15 ng/ml or 20 ng/ml in these reference studies as 
cut off values for vitamin D deficiency increases the number of children 
in the deficiency group in the above studies. Standard value for cut off for 
vitamin D levels is 10 ng/ml(77). Though different researchers have 
indicated the need for raising the cut off to 15 or 20 ng/ml, as the 
parathormone level starts increasing with these levels of 25 OH vitamin 
D, and is being used as cut off in US and other countries, there has been 
no recommendation to change the cut off value in India as of now. So we 
have conducted our study with cut off value for 25 OH vitamin D 
deficiency as 10 ng/ml. 
USAGE OF ANTIEPILEPTICS & SEIZURES VS VITAMIN D 
In a population based study (15), 38% of children with CP had 
epilepsy but in our study 75 % had seizures. Our hospital being a tertiary 
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care centre, we had a higher prevalence of seizure disorder in CP in our 
study due to higher referral rates for refractory seizures. 
In our study, majority 24 (75%) of them were on anticonvulsants 
and the commonly used anticonvulsant was valproate constituting 68.5% 
of the total.  43.75% children were on phenytoin and 46.85% children 
were on phenobarbitone.  
But alteration of vitamin D status due to individual AEDs could not 
be analyzed as most patients were on polytherapy and co relation with 
vitamin D deficiency could not be obtained. 
DURATION OF AED VS. VITAMIN D 
The duration of AED intake has been found to be statistically 
significant in altering vitamin D levels. Longer the duration of intake, 
higher is the alteration. This has also been found to be the same as in 
earlier studies, which show alteration to low values and also decreased 
BMD with, chronic anti convulsant usage. (47, 48). 
Reports of altered calcium, vitamin D, and bone metabolism 
associated with anticonvulsant medication use are numerous. 
Biochemical abnormalities have included decreased serum calcium, 25-
hydroxycholecalciferol (calcidiol), and phosphorus, and elevated alkaline 
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phosphatase (AP) (41, 78), although other investigators have found no 
association between anticonvulsant use and one or more of these 
variables (79, 80). In our study, Vitamin D deficiency has been 
significantly associated with low serum phosphorous levels.   Probably 
the stage of vitamin D disease, though deficient, is in a compensated state 
due to increased parathormone levels or probably performing ionic 
calcium studies would reflect low calcium levels better.  
FEEDING DIFFICULTY VS. VITAMIN D 
Children with cerebral palsy consume less dietary energy than 
unaffected children. A high proportion of children with cerebral palsy 
(CP) are growth retarded and underweight (81). Under nutrition has been 
documented in 29% to 46% of children with cerebral palsy (82, 83) while 
in our study 26 (81.3%) were undernourished. Wasting was statistically 
significant in our data and it contributed to vitamin D deficiency.  
Feeding problems occur frequently in children with cerebral palsy 
(11, 83). Inability to suck, problems associated with breast-feeding, 
difficulty in the introduction of solid foods, problems with drinking 
liquids, inability in  biting or chewing solids, and coughing and choking 
during meals were usual parental complaints in our study. 
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Feeding difficulties were observed in 81.3% of children in our 
study and it was statistically significant when compared with vitamin D 
status. The commonest difficulty encountered is the prolonged feeding 
time due to difficulty in swallowing, tongue thrusting, and aspirations. 
Children with cerebral palsy take two to twelve times longer to swallow 
mashed food and up to fifteen times longer to chew and swallow solids 
compared with normal children. Longer mealtimes may not compensate 
for their feeding difficulty (57). In one report, 28% of parents required 
more than 3 hours daily to feed their child and 3% required more than 6 
hours daily (84).   
Minerals like Iron, selenium, zinc, essential fatty acids, and 
vitamins C, D, and E were found to be deficient in 15% to 50% of these 
populations (64, 85, and 86). 
FRACTURES & DENTAL CHANGES VS VITAMIN D 
Osteopenia is prevalent in neurologically impaired children (64). 
Inadequate supply of critical nutrients for bone formation adds to the 
negative impact of immobility, lack of weight-bearing and use of anti-
convulsants on bone health, and may also cause reduced muscle strength. 
In our study, fractures were seen in only 3 (9.4%) of the children and this 
was not statistically significant with Vitamin D status. 
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Quadriplegics are mostly associated with fractures and all the three 
children who had fractures were quadriplegics. An increased amount of 
long-bone fractures has been seen in children and adolescents with 
quadriplegic cerebral palsy in residential setup and conclusion was given 
that vitamin D deficiency was the major point contributing to the 
occurrence of fractures in the population studied. (87)  
At the same time dental changes were seen in 53.1% which was 
statistically significant when compared to vitamin D levels. 
TYPE OF CEREBRAL PALSY VS. VITAMIN D 
In our study, spastic quadriparesis constituted the most common 
type of CP seen in 59.37%, spastic diplegia in 12.5%, hempiplegia in 
15.62% and dyskinetic 12.5% each. There were a significant statistical 
association between the type of CP and the vitamin D status. 
Ünay B et al (88) in their analysis have demonstrated that BMD of 
the children with CP was very low when compared to the normal 
children, and that quadriplegic CP type were more  prone to have low 
bone mineralization than hemiplegic patients. 
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SUNLIGHT EXPOSURE & FUNCTIONAL  GRADE  VS  
VITAMIN D 
In our study, poor sunlight exposure was seen in 68.75 % of the CP 
children and there was a significant association between poor sunlight 
exposure and the presence of Vitamin D deficiency / insufficiency which 
have been well supported in literature as mentioned earlier. 
In our study, 2 (6.3%) belonged to functional grade 2, 11(34.4%) 
belonged to functional grade 3 and 19 (59.4%) belonged to functional 
grade 4. There was a significant correlation between non ambulation and 
osteopenia in children with CP as in other studies (78, 89). 
The major reason for the poor sunlight exposure was their non 
ambulant nature as functional grade IV was observed in 59.3%. Bischof 
et al in their study have stressed unless sunlight exposure is guaranteed, 
vitamin D supplementation should be considered in children especially if 
they are on AED (87).  
However, more studies with a larger sample size on the Vitamin D 
status on various pediatric age groups and comparison studies with high 
risk population such as cerebral palsy are necessary before any concrete 
conclusions can be made as most of the studies published have 
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highlighted the same. All the variables have to be studied prospectively 
and logistically to get a stronger recommendable conclusion. 
ANALYSIS OF LABORATORY DATA 
In our study of 32 CP children, 24(75%) of children had low 
calcium, 12 (37.5%) had low phosphorus and the rest were normal. 
Serum Alkaline phosphatase (SAP) was normal in 16 (50%) of children 
while the levels were elevated in 46.8% of CP children. When comparing 
this with control population, Phosphorus and calcium were statistically 
significant in deficiency and insufficiency group respectively. 
Hals et al. found vitamin D deficiency (25-OH-vitaminD3 < 25 
nmol/L) in three out of 13 disabled patients, despite regular vitamin 
supplementation (85) which accounts to 23%. The percentage of children 
with Vitamin D deficiency was found to be 14.4% and Vitamin D 
insufficiency was 4.8%. The overall abnormalities in Vitamin D status 
was found in 19.2%.  
VITAMIN D SUPPLEMENTATION 
Fisher in 1988 have recommended 4000 IU/m2/day of vitamin D 
for children with CP and Lee recommended 1000 IU/day. Jekovec-
Vrhovšek in 2000 (90) have studied the baseline BMD in children with 
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CP and compared the bone density after 9 months of administering 
0.25mcg /day of calcitriol and 500mg/day of calcium and have found 
significant increase in the BMD after treatment. Though American 
academy of Pediatrics in their clinical report (17) have recommended 
higher dose of Vitamin D in those at risk, no clear consensus have been 
made regarding the exact dosage regimen for children with CP. 
LIMITATIONS 
Ideally the vitamin D levels should have been compared with 
parathormone levels to give the study a fulfillment but due to cost 
constraints the same could not be done. We wish a larger prospective case 
control study will bring out much more details to form some kind of 
recommendations 
The other limitation was not performing bone mineral density in 
our study subjects as this would have made the study throw a light on the 
bone mineral density status in children with cerebral palsy as no literature 
on the same is available in Indian children. The reasons for not 
performing bone mineral density was the difficulty to perform the test in 
these patients technically, non availability of reference standards in 
Indian children to compare the results, difficulty in getting matched 
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controls as healthy subjects could not be compared with children with CP 
and the cost involved in performing the test. 
Vitamin D deficiency being a preventable condition, a proactive 
approach is needed to target these potential risk factors to suspect and 
thereby treat whenever required. Regular nutritional assessment is 
necessary to identify malnourished children. Gastrostomy tube placement 
should be considered early in their nutritional rehabilitation programme. 
Parental education regarding the need for adequate sunlight exposure 
should also be stressed. Vitamin D and calcium supplementation should 
be considered in those at risk. As the prevalence of vitamin D deficiency 
is reported to be high in otherwise healthy subjects, further studies are 
required to have clear consensus regarding prophylactic calcium and 
vitamin D supplements, their dosage and duration of the treatment in high 
risk groups like cerebral palsy. 
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CONCLUSION 
The prevalence of vitamin D deficiency in children with CP was 
found to be 37.5% while insufficiency amounted to 56.3% and a total 
alteration in vitamin D status in CP children was 93.8%. The prevalence 
of vitamin D deficiency in age and sex matched controls  was found to be 
3.13% while insufficiency amounted to 37.5% and a total alteration in 
vitamin D status  was 40.63%. The presence of feeding difficulties, poor 
sunlight exposure, poor nutritional status, and the use of antiepileptic 
drugs, type of CP and the functional grade of CP had statistically 
significant association with Vitamin D deficiency in these children. 
Periodic monitoring, early identification and appropriate calcium and 
vitamin D supplements may prevent complications like fractures, etc. 
Hypovitaminosis D is very common and represents latent stage of vitamin 
D deficiency. Appropriate treatment with vitamin D supplements and 
calcium is necessary for treatment of vitamin deficiency and 
replenishment of stores. 
age sex 1=m 2=f delivery 1=nor 2=em 3 =el gest 1= pre 2= term 3= post ba 1=y 2=n
5 2 1 2 1
1 2 3 2 1
4 1 1 1 1
1 1 1 1 2
4 2 1 1 2
5 1 2 2 1
1 2 2 2 1
10 1 1 2 1
6 2 1 2 2
2 2 1 2 2
3 2 1 2 2
2 1 1 2 2
11 1 1 2 2
7 1 1 2 2
8 1 1 1 2
3 1 1 2 2
12 1 2 2 2
9 2 1 2 2
10 1 2 2 1
6 2 1 2 2
9 1 2 2 1
7 2 2 2 1
3 2 2 2 1
8 2 1 2 2
2 1 2 2 2
12 2 1 2 2
7 1 1 1 2
1 1 2 2 2
11 2 1 2 2
4 1 1 2 2
10 1 2 2 1
5 2 2 2 2
bw1=<2.5 2=>2.5 n.seizures1=y 2=n bf 1=y 2=n d delay 1=y 2=nepilptic 1=y 2=naed 1=y 2=naed years
1 1 1 1 2 2 0
2 1 1 1 2 2 0
1 2 2 1 1 1 3
1 2 1 1 2 2 0
1 2 1 1 1 1 3
2 1 1 1 1 1 3
2 2 1 1 1 1 0.1
2 2 1 1 1 1 4
2 2 1 1 1 1 3
2 2 1 1 1 1 2
2 2 1 1 1 1 3
2 2 1 1 1 1 2
2 2 1 1 1 1 10
2 2 1 1 1 1 6
1 2 1 1 1 1 3
2 2 1 1 2 2 0
2 2 1 1 1 1 7
2 2 1 1 1 1 5
2 1 1 1 1 1 10
2 2 1 1 2 2 0
2 2 1 1 1 1 7
2 1 1 1 1 1 6
2 2 1 1 1 1 2
2 2 1 1 1 1 5
2 2 1 1 2 2 0
2 2 1 1 1 1 8
2 2 1 1 2 2 0
2 2 1 1 1 1 0.7
2 2 2 1 1 1 7
2 2 1 1 2 2 0
2 1 1 1 1 1 9
2 2 1 1 1 1 4
fd 1=y 2=n cons 1=y 2=nsunlight 1=y 2=nden 1=y 2=nfrac 1=y 2=n mic y=1 n=2 was y=1 n=2 calc1=<7 2=7 to 9 3=9-11 4=>11
2 2 1 2 2 1 1 2
2 2 1 1 2 1 2 3
2 1 1 1 2 1 1 2
1 2 1 2 2 2 2 2
2 2 1 1 2 1 2 3
1 1 2 1 1 1 1 2
1 1 2 2 2 1 1 3
1 2 1 1 2 1 1 2
1 1 2 2 2 1 1 2
1 2 2 2 2 1 1 2
1 2 2 1 2 1 1 2
1 2 2 1 2 1 1 2
1 1 2 1 2 1 1 1
1 2 1 1 2 1 1 2
1 2 1 1 2 1 1 3
1 2 1 2 2 1 1 3
1 2 1 2 2 1 1 2
1 1 2 2 2 1 1 2
1 2 2 2 1 1 1 2
2 2 1 2 2 2 2 3
2 2 1 1 2 1 1 3
1 1 1 1 2 1 1 2
1 2 1 1 2 1 1 2
2 2 1 2 2 1 2 2
2 2 1 2 2 2 1 3
1 2 1 1 2 1 1 2
2 2 1 2 2 1 2 2
1 2 1 2 2 1 1 2
1 1 1 1 2 1 1 2
1 2 1 2 2 2 1 2
1 1 1 1 2 1 1 2
1 1 2 1 1 1 1 2
phos1=<3.5, 2=3.5-5.5, 3>5.5alp 1=<150 2=150-400 3=>400vit d 1=<10 2=10-30 3=30-100 4=>100calcium phosphorus
2 2 2 8.2 3.5
2 2 3 9.2 4
1 3 1 8 3.2
2 2 2 9 3.5
2 2 2 9 3.5
1 3 1 7 3.4
2 2 2 9 4.5
2 2 2 9 4.5
1 3 1 7.6 3.2
2 2 2 8.8 4.5
2 3 1 8.6 3.4
1 3 2 7.5 3.2
1 3 1 6.8 2.5
2 3 1 7.4 3.5
2 2 2 9.6 4.5
2 2 2 9.4 4.5
1 3 1 7 3.2
1 3 2 7.4 2.8
1 3 1 7 3
2 2 2 8.6 3.5
2 2 2 9 3.5
1 3 1 8.5 3.2
1 3 1 7.8 3
2 1 2 8.8 3.5
2 2 2 9 3.5
1 3 2 7.2 3.2
2 2 2 9 3.5
2 3 1 7.8 3.2
1 2 1 7 3.2
2 2 2 8.2 3.8
2 3 3 8.4 4
2 2 2 8.2 3.8
alp vit d no of aed eptoin 1=y 2=npheno 1=y 2=nvalp 1=y 2=ncar y=1 n=2top y=1 n=2lamo 1=y 2=nnil 1=y 2=n
300 28.82 0 2 2 2 2 2 2 1
300 34.52 0 2 2 2 2 2 2 1
450 9.88 2 1 2 1 2 2 2 2
350 15.4 0 2 2 2 2 2 2 2
400 13.3 1 1 2 2 2 2 2 2
500 9.63 2 2 2 1 2 2 1 2
250 24 2 1 2 1 2 2 2 2
360 29.9 1 2 2 1 2 2 2 2
480 6.21 1 2 1 2 2 2 2 2
250 10.2 2 2 1 1 2 2 2 2
450 7.86 2 2 1 1 2 2 2 2
500 24.1 1 2 1 2 2 2 2 2
800 3.9 3 1 1 1 2 2 2 2
485 7.8 3 1 1 1 2 2 2 2
250 29.3 1 2 2 1 2 2 2 2
280 25.2 0 2 2 2 2 2 2 1
480 9.9 3 1 1 1 2 2 2 2
800 28.6 4 1 1 1 2 2 2 2
600 8 4 2 2 1 2 2 1 2
284 21.44 0 2 2 2 2 2 2 1
340 23.42 1 2 2 1 2 2 2 2
478 8.66 3 1 1 1 2 2 2 2
480 6.62 3 1 1 1 2 2 2 2
380 28.6 1 1 2 2 2 2 2 2
300 28 0 2 2 2 2 2 2 1
560 10 3 1 1 1 2 2 2 2
350 23.4 0 2 2 2 2 2 2 1
600 6.88 3 1 1 1 2 2 2 2
600 6.28 3 1 1 1 2 2 2 2
400 24.2 0 2 2 2 2 2 2 1
380 34.8 3 1 1 1 2 2 2 2
365 26.8 2 2 1 1 2 2 2 1
duration 1= <1 2=1-3 3=>3 4=niltype of cp hemi=1 quad=2 diple=3 ataxic=4 dysk=5 others +6 nil = 7ft grade
4 2 4
4 5 2
3 1 3
4 3 3
2 5 3
3 2 4
1 2 4
3 5 3
2 2 4
1 2 4
3 2 4
2 2 4
3 2 4
3 2 4
3 1 3
4 2 4
3 1 3
3 2 4
3 2 4
4 3 2
3 1 3
3 2 4
2 2 4
3 1 3
4 3 3
3 2 4
4 5 3
1 2 4
3 2 4
4 3 3
2 2 4
1 2 4
age sex 1=m 2=f delivery 1=nor 2=em 3 =el gest pre=1 term=2 post=3 ba 1=y 2=n
5 2 1 2 2
1 2 1 2 2
4 1 1 2 2
1 1 2 2 2
4 2 3 2 2
5 1 1 2 2
1 2 2 2 2
10 1 3 2 2
6 2 1 2 2
2 2 2 2 2
3 2 3 2 2
2 1 1 2 2
11 1 2 2 2
7 1 3 2 2
8 1 1 2 2
3 1 2 2 2
12 1 3 2 2
9 2 1 2 2
10 1 2 2 2
6 2 3 2 2
9 1 1 2 2
7 2 2 2 2
3 2 3 2 2
8 2 1 2 2
2 1 2 2 2
12 2 3 2 2
7 1 1 2 2
1 1 2 2 2
11 2 3 2 2
4 1 1 2 2
10 1 2 2 2
5 2 3 2 2
bw1=<2.5 2=>2.5 n.seizures1=y 2=n bf 1=y 2=n d delay 1=y 2=nepilptic 1=y 2=naed 1=y 2=naed years
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
2 2 1 2 2 2 0
fd 1=y 2=n cons 1=y 2=nsunlight 1=y 2=nden 1=y 2=n frac 1=y 2=n mic y=1 n=2 was y=1 n=2 calc1=<7 2=7 to 9 3=9-11 4=>11
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
2 2 1 2 2 2 2 3
2 2 1 2 2 2 2 2
phos1=<3.5, 2=3.5-5.5, 3>5.5alp 1=<150 2=150-400 3=>400 vit d 1=<10 2=10-30 3=30-100 4=>100cal phos
2 2 3 9.6 4
2 2 3 9.2 3.8
2 2 3 9 4.5
2 2 3 9.4 4.2
2 3 1 8.8 3.8
2 2 2 9.2 4.2
2 2 3 9.2 4.5
2 2 3 9.2 4.8
2 2 2 8.6 3.8
2 2 3 9.4 4.8
2 2 3 9.6 4
2 3 2 8.4 3.8
2 2 2 9.2 3.6
2 3 2 8.8 3.8
2 2 2 9.6 4
2 2 3 10.2 5
2 2 3 10.4 4.8
2 2 3 9.6 4
2 2 2 9 3.6
2 2 3 9.6 4
2 2 3 9 3.6
2 2 3 9.4 4.6
2 2 3 9.2 4.5
2 3 2 8.8 3.6
2 2 3 9.8 4.2
2 2 2 9.8 3.8
2 2 3 9.4 4.2
2 2 3 9.2 4
2 2 3 10.4 5
2 3 2 8.8 3.8
2 2 2 9.8 4.2
2 3 2 8.8 4
alp vit d no of aed phe 1=y 2=npheno 1=y 2=nvalp 1=y 2=ncar1=y 2=n top 1=y 2=nlamo 1=y 2=n
160 41.66 0 2 2 2 2 2 2
160 54.52 0 2 2 2 2 2 2
168 31.8 0 2 2 2 2 2 2
188 38 0 2 2 2 2 2 2
680 9.37 0 2 2 2 2 2 2
388 19.3 0 2 2 2 2 2 2
182 36.88 0 2 2 2 2 2 2
220 34.6 0 2 2 2 2 2 2
188 21.6 0 2 2 2 2 2 2
150 55.8 0 2 2 2 2 2 2
168 30.6 0 2 2 2 2 2 2
500 25.3 0 2 2 2 2 2 2
392 19.8 0 2 2 2 2 2 2
480 23.4 0 2 2 2 2 2 2
400 26.1 0 2 2 2 2 2 2
150 88.1 0 2 2 2 2 2 2
158 79.4 0 2 2 2 2 2 2
358 48.4 0 2 2 2 2 2 2
400 10.7 0 2 2 2 2 2 2
162 35.8 0 2 2 2 2 2 2
400 11 0 2 2 2 2 2 2
182 33.4 0 2 2 2 2 2 2
168 30.4 0 2 2 2 2 2 2
460 10.9 0 2 2 2 2 2 2
192 34.6 0 2 2 2 2 2 2
388 17.8 0 2 2 2 2 2 2
162 33.4 0 2 2 2 2 2 2
182 32.3 0 2 2 2 2 2 2
158 60.3 0 2 2 2 2 2 2
490 19.1 0 2 2 2 2 2 2
368 24.4 0 2 2 2 2 2 2
460 21.6 0 2 2 2 2 2 2
nil 1=y 2=n duration 1= <1 2=1-3 3=>3  4= niltype of cp hemi=1 quad=2 diple=3 ataxic=4 dysk=5 others +6 nil = 7ft grade
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
1 4 7 0
 
